Pituitary volume, stress reactivity and genetic risk for psychotic disorder

Psychological Medicine

Volumn 42, Issue 7, 2012, Pages 1523-1533

  Habets, P ^a   Collip, D ^a   Myin Germeys, I ^a   Gronenschild, E ^a   Van Bronswijk, S ^a   Hofman, P ^a   Lataster, T ^a   Lardinois, M ^a   Nicolson, N A ^a   Van Os, J ^a,b   Marcelis, M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Genetic predisposition to disease; hypothalamo hypophyseal system; magnetic resonance imaging; pituitary gland; pituitary adrenal system; psychological stress; schizophrenia; stress

Indexed keywords

HYDROCORTISONE;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; HYPOPHYSIS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; MENTAL STRESS; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOSIS; REGRESSION ANALYSIS; SALIVA; SCHIZOPHRENIA; SELF REPORT; SIBLING;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PITUITARY GLAND; PITUITARY-ADRENAL SYSTEM; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; SALIVA; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF REPORT; SIBLINGS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84861444284     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291711002728     Document Type: Article

References (54)

1. Abech DD, Moratelli HB, Leite SC, Oliveira MC (2005). Effects of estrogen replacement therapy on pituitary size, prolactin and thyroid-stimulating hormone concentrations in menopausal women. Gynecological Endocrinology 21, 223-226. (Pubitemid 41769999)
2. Andreasen NC, Flaum M, Arndt S (1992). The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615-623.
3. APA (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). American Psychiatric Association: Washington, DC.
4. Boerma MA, van der Stel JC, van Amelsvoort T, Linszen DH, de Haan L (2010). Women, schizophrenia and estrogen ; neurobiological hypotheses and hormone therapy studies [in Dutch]. Tijdschrift voor Psychiatrie 52, 235-244.
5. Brenner K, Liu A, Laplante DP, Lupien S, Pruessner JC, Ciampi A, Joober R, King S (2009). Cortisol response to a psychosocial stressor in schizophrenia: blunted, delayed, or normal? Psychoneuroendocrinology 34, 859-868.
6. Clayton D, Hills M (1993). Statistical Models in Epidemiology. Oxford University Press: Oxford.
7. Collip D, Myin-Germeys I, van Os J (2008). Does the concept of ' sensitization ' provide a plausible mechanism for the putative link between the environment and schizophreniÄSchizophrenia Bulletin 34, 220-225. (Pubitemid 351323342)
8. Collip D, Nicolson NA, Lardinois M, Lataster T, van Os J, Myin-Germeys I (2011). Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychological Medicine 41, 2305-2315.
9. Crow TJ (1980). Molecular pathology of schizophrenia: more than one disease process? British Medical Journal 280, 66-68. (Pubitemid 10199277)
10. Csikszentmihalyi M, Larson R (1987). Validity and reliability of the Experience-Sampling Method. Journal of Nervous and Mental Disease 175, 526-536. (Pubitemid 17144371)
11. Dale AM, Fischl B, Sereno MI (1999). Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage 9, 179-194. (Pubitemid 29369874)
12. Delespaul P, deVries M, van Os J (2002). Determinants of occurrence and recovery from hallucinations in daily life. Social Psychiatry and Psychiatric Epidemiology 37, 97-104. (Pubitemid 36097264)
13. Doraiswamy PM, Potts JM, Axelson DA, Husain MM, Lurie SN, Na C, Escalona PR, McDonald WM, Figiel GS, Ellinwood Jr. EH (1992). MR assessment of pituitary gland morphology in healthy volunteers: age-and genderrelated differences. American Journal of Neuroradiology 13, 1295-1299.
14. Fischl B, Sereno MI, Dale AM (1999). Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. NeuroImage 9, 195-207. (Pubitemid 29369875)
15. Garner B, Pariante CM, Wood SJ, Velakoulis D, Phillips L, Soulsby B, Brewer WJ, Smith DJ, Dazzan P, Berger GE, Yung AR, van den Buuse M, Murray R, McGorry PD, Pantelis C (2005). Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry 58, 417-423. (Pubitemid 41219710)
16. Grams AE, Gempt J, Stahl A, Forschler A (2010). Female pituitary size in relation to age and hormonal factors. Neuroendocrinology 92, 128-132.
17. Green AS, Rafaeli E, Bolger N, Shrout PE, Reis HT (2006). Paper or plastic? Data equivalence in paper and electronic diaries. Psychological Methods 11, 87-105. (Pubitemid 44084653)
18. Gronenschild EH, Burgmans S, Smeets F, Vuurman EF, Uylings HB, Jolles J (2010). A time-saving and facilitating approach for segmentation of anatomically defined cortical regions: MRI volumetry. Psychiatry Research 181, 211-218.
19. Habets P, Marcelis M, Gronenschild E, Drukker M, van Os J (2011). Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biological Psychiatry 69, 487-494.
20. Herz MI, Fava GA, Molnar G, Edwards L (1985). The dexamethasone suppression test in newly hospitalized schizophrenic patients. American Journal of Psychiatry 142, 127-129. (Pubitemid 15189541)
21. Jovicich J, Czanner S, Han X, Salat D, van der Kouwe A, Quinn B, Pacheco J, Albert M, Killiany R, Blacker D, Maguire P, Rosas D, Makris N, Gollub R, Dale A, Dickerson BC, Fischl B (2009). MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. NeuroImage 46, 177-192.
22. Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276. (Pubitemid 18039085)
23. Lammers CH, Garcia-Borreguero D, Schmider J, Gotthardt U, Dettling M, Holsboer F, Heuser IJ (1995). Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II. Biological Psychiatry 38, 803-807. (Pubitemid 3020007)
24. Lardinois M, Lataster T, Mengelers R, van Os J, Myin-Germeys I (2010). Childhood trauma and increased stress sensitivity in psychosis. Acta Psychiatrica Scandinavica 123, 28-35.
25. Lataster T, Collip D, Lardinois M, van Os J, Myin-Germeys I (2010). Evidence for a familial correlation between increased reactivity to stress and positive psychotic symptoms. Acta Psychiatrica Scandinavica 122, 395-404.
26. MacMaster FP, El-Sheikh R, Upadhyaya AR, Nutche J, Rosenberg DR, Keshavan M (2007). Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: a pilot study. Schizophrenia Research 92, 207-210. (Pubitemid 46561231)
27. Marcelis M, Cavalier E, Gielen J, Delespaul P, van Os J (2004). Abnormal response to metabolic stress in schizophrenia: marker of vulnerability or acquired sensitization? Psychological Medicine 34, 1103-1111. (Pubitemid 39199979)
28. Mondelli V, Dazzan P, Gabilondo A, Tournikioti K, Walshe M, Marshall N, Schulze KK, Murray RM, McDonald C, Pariante CM (2008). Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 33, 1004-1012.
29. Mondelli V, Dazzan P, Hepgul N, Di Forti M, Aas M, D'Albenzio A, Di Nicola M, Fisher H, Handley R, Marques TR, Morgan C, Navari S, Taylor H, Papadopoulos A, Aitchison KJ, Murray RM, Pariante CM (2010). Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophrenia Research 116, 234-242.
30. Murray RM, O'Callaghan E, Castle DJ, Lewis SW (1992). A neurodevelopmental approach to the classification of schizophrenia. Schizophrenia Bulletin 18, 319-332.
31. Myin-Germeys I, Delespaul P, van Os J (2005). Behavioural sensitization to daily life stress in psychosis. Psychological Medicine 35, 733-741. (Pubitemid 40716437)
32. Myin-Germeys I, Krabbendam L, Delespaul PA, van Os J (2003). Do life events have their effect on psychosis by influencing the emotional reactivity to daily life stress? Psychological Medicine 33, 327-333. (Pubitemid 36221464)
33. Myin-Germeys I, Oorschot M, Collip D, Lataster J, Delespaul P, van Os J (2009). Experience sampling research in psychopathology: opening the black box of daily life. Psychological Medicine 39, 1533-1547.
34. Myin-Germeys I, van Os J (2007). Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clinical Psychology Review 27, 409-424. (Pubitemid 46420798)
35. Myin-Germeys I, van Os J, Schwartz JE, Stone AA, Delespaul PA (2001). Emotional reactivity to daily life stress in psychosis. Archives of General Psychiatry 58, 1137-1144. (Pubitemid 33121505)
36. Nicolo JP, Berger GE, Garner BA, Velakoulis D, Markulev C, Kerr M, McGorry PD, Proffitt TM, McConchie M, Pantelis C, Wood SJ (2010). The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: a longitudinal MRI study. Schizophrenia Research 116, 49-54.
37. Pariante CM (2006). The glucocorticoid receptor: part of the solution or part of the problem? Journal of Psychopharmacology 20, 79-84. (Pubitemid 44576663)
38. Pariante CM, Dazzan P, Danese A, Morgan KD, Brudaglio F, Morgan C, Fearon P, Orr K, Hutchinson G, Pantelis C, Velakoulis D, Jones PB, Leff J, Murray, RM (2005). Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the?sop first-onset psychosis study. Neuropsychopharmacology 30, 1923-1931. (Pubitemid 41486417)
39. Pariante CM, Vassilopoulou K, Velakoulis D, Phillips L, Soulsby B, Wood SJ, Brewer W, Smith DJ, Dazzan P, Yung AR, Zervas IM, Christodoulou GN, Murray R, McGorry PD, Pantelis C (2004). Pituitary volume in psychosis. British Journal of Psychiatry 185, 5-10. (Pubitemid 38951623)
40. Phillips LJ, McGorry PD, Garner B, Thompson KN, Pantelis C, Wood SJ, Berger G (2006). Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. Australian and New Zealand Journal of Psychiatry 40, 725-741. (Pubitemid 44145215)
41. Robins E, Guze SB (1970). Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. American Journal of Psychiatry 126, 983-987.
42. Ryan MC, Sharifi N, Condren R, Thakore JH (2004). Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia. Psychoneuroendocrinology 29, 1065-1070. (Pubitemid 38833534)
43. Sassi RB, Nicoletti M, Brambilla P, Harenski K, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC (2001). Decreased pituitary volume in patients with bipolar disorder. Biological Psychiatry 50, 271-280. (Pubitemid 32778444)
44. StataCorp 2009 Stata Statistical Software: Release 11. StataCorp LP: College Station, TX.
45. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR (2002). Patient non-compliance with paper diaries. British Medical Journal 324, 1193-1194. (Pubitemid 34547922)
46. Sulon J, Demey-Ponsart L, Beauduin P, Sodoyez JC (1978). Radioimmunoassay of corticosterone, cortisol and cortisone: their application to human cord and maternal plasma. Journal of Steroid Biochemistry 9, 671-676. (Pubitemid 9015107)
47. Takahashi T, Suzuki M, Velakoulis D, Lorenzetti V, Soulsby B, Zhou SY, Nakamura K, Seto H, Kurachi M, Pantelis C (2009). Increased pituitary volume in schizophrenia spectrum disorders. Schizophrenia Research 108, 114-121.
48. Tournikioti K, Tansella M, Perlini C, Rambaldelli G, Cerini R, Versace A, Andreone N, Dusi N, Balestrieri M, Malago R, Gasparini A, Brambilla P (2007). Normal pituitary volumes in chronic schizophrenia. Psychiatry Research 154, 41-48. (Pubitemid 46072706)
49. Upadhyaya AR, El-Sheikh R, MacMaster FP, Diwadkar VA, Keshavan MS (2007). Pituitary volume in neuroleptic-nai ve schizophrenia: a structural MRI study. Schizophrenia Research 90, 266-273. (Pubitemid 46177556)
50. Van Os J, Gilvarry C, Bale R, Van Horn E, Tattan T, White I, Murray R (1999). A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychological Medicine 29, 595-606. (Pubitemid 29261347)
51. Van Venrooij JA, Fluitman SB, Lijmer JG, Kavelaars A, Heijnen CJ, Westenberg HG, Kahn RS, Gispen-de Wied CC (2010). Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophrenia Bulletin. Published online: 17 June 2010. doi:10.1093/schbul/sbq062.
52. Walker EF, Brennan PA, Esterberg M, Brasfield J, Pearce B, Compton MT (2010). Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth. Journal of Abnormal Psychology 119, 401-408.
53. Walker EF, Diforio D (1997). Schizophrenia: a neural diathesis-stress model. Psychological Review 104, 667-685. (Pubitemid 127499376)
54. WHO (1990). Composite International Diagnostic Interview (CIDI). World Health Organization: Geneva.